S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.68 (-0.31%)
AAPL   137.59 (+0.17%)
MSFT   252.56 (-0.23%)
FB   193.54 (+1.18%)
GOOGL   2,178.16 (-1.34%)
AMZN   2,151.82 (+0.25%)
TSLA   663.90 (-6.42%)
NVDA   166.94 (-2.51%)
BABA   86.79 (-1.03%)
NIO   16.44 (-1.32%)
AMD   93.50 (-3.28%)
CGC   5.52 (-5.96%)
MU   68.90 (-0.72%)
T   20.40 (+0.94%)
GE   75.25 (-0.65%)
F   12.50 (-2.72%)
DIS   102.42 (-0.70%)
AMC   12.03 (-8.03%)
PFE   52.47 (+3.59%)
PYPL   80.54 (-0.91%)
NFLX   186.35 (+1.56%)
S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.68 (-0.31%)
AAPL   137.59 (+0.17%)
MSFT   252.56 (-0.23%)
FB   193.54 (+1.18%)
GOOGL   2,178.16 (-1.34%)
AMZN   2,151.82 (+0.25%)
TSLA   663.90 (-6.42%)
NVDA   166.94 (-2.51%)
BABA   86.79 (-1.03%)
NIO   16.44 (-1.32%)
AMD   93.50 (-3.28%)
CGC   5.52 (-5.96%)
MU   68.90 (-0.72%)
T   20.40 (+0.94%)
GE   75.25 (-0.65%)
F   12.50 (-2.72%)
DIS   102.42 (-0.70%)
AMC   12.03 (-8.03%)
PFE   52.47 (+3.59%)
PYPL   80.54 (-0.91%)
NFLX   186.35 (+1.56%)
S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.68 (-0.31%)
AAPL   137.59 (+0.17%)
MSFT   252.56 (-0.23%)
FB   193.54 (+1.18%)
GOOGL   2,178.16 (-1.34%)
AMZN   2,151.82 (+0.25%)
TSLA   663.90 (-6.42%)
NVDA   166.94 (-2.51%)
BABA   86.79 (-1.03%)
NIO   16.44 (-1.32%)
AMD   93.50 (-3.28%)
CGC   5.52 (-5.96%)
MU   68.90 (-0.72%)
T   20.40 (+0.94%)
GE   75.25 (-0.65%)
F   12.50 (-2.72%)
DIS   102.42 (-0.70%)
AMC   12.03 (-8.03%)
PFE   52.47 (+3.59%)
PYPL   80.54 (-0.91%)
NFLX   186.35 (+1.56%)
S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.68 (-0.31%)
AAPL   137.59 (+0.17%)
MSFT   252.56 (-0.23%)
FB   193.54 (+1.18%)
GOOGL   2,178.16 (-1.34%)
AMZN   2,151.82 (+0.25%)
TSLA   663.90 (-6.42%)
NVDA   166.94 (-2.51%)
BABA   86.79 (-1.03%)
NIO   16.44 (-1.32%)
AMD   93.50 (-3.28%)
CGC   5.52 (-5.96%)
MU   68.90 (-0.72%)
T   20.40 (+0.94%)
GE   75.25 (-0.65%)
F   12.50 (-2.72%)
DIS   102.42 (-0.70%)
AMC   12.03 (-8.03%)
PFE   52.47 (+3.59%)
PYPL   80.54 (-0.91%)
NFLX   186.35 (+1.56%)
NASDAQ:MICT

MICT (MICT) Stock Forecast, Price & News

$0.73
-0.01 (-1.35%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.71
$0.76
50-Day Range
$0.43
$0.74
52-Week Range
$0.41
$2.60
Volume
333,496 shs
Average Volume
1.17 million shs
Market Capitalization
$89.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.03
30 days | 90 days | 365 days | Advanced Chart
Receive MICT News and Ratings via Email

Sign-up to receive the latest news and ratings for MICT and its competitors with MarketBeat's FREE daily newsletter.

MICT logo

About MICT

MICT, Inc., through its subsidiaries, designs, develops, manufactures, and sells mobile computing devices and software for fleet operators and field workforces. It also engages in the provision of online brokerage services for equities trading and the sale of insurance products through a proprietary trading technology platform. In addition, the company offers online investment and wealth management services, as well as trades in commodities. It serves in the United States, Israel, Europe, China, and internationally. The company was formerly known as Micronet Enertec Technologies, Inc. and changed its name to MICT, Inc. in July 2018. MICT, Inc. was founded in 2002 and is headquartered in Montvale, New Jersey.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Electronic components & accessories
Sub-Industry
N/A
Current Symbol
NASDAQ:MICT
Fax
N/A
Employees
5
Year Founded
N/A

Sales & Book Value

Annual Sales
$1.17 million
Book Value
$0.96 per share

Profitability

Net Income
$-22.97 million
Pretax Margin
-90.51%

Debt

Price-To-Earnings

Miscellaneous

Free Float
120,428,000
Market Cap
$89.51 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/15/2021
Today
5/20/2022
Next Earnings (Estimated)
5/23/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.70 out of 5 stars

Computer And Technology Sector

572nd out of 924 stocks

Electronic Components & Accessories Industry

8th out of 11 stocks

Analyst Opinion: 3.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -













MICT (NASDAQ:MICT) Frequently Asked Questions

Is MICT a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for MICT in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MICT stock.
View analyst ratings for MICT
or view top-rated stocks.

When is MICT's next earnings date?

MICT is scheduled to release its next quarterly earnings announcement on Monday, May 23rd 2022.
View our earnings forecast for MICT
.

How were MICT's earnings last quarter?

MICT, Inc. (NASDAQ:MICT) announced its earnings results on Monday, November, 15th. The company reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.02. The business earned $18.52 million during the quarter. MICT had a negative trailing twelve-month return on equity of 24.21% and a negative net margin of 87.65%.
View MICT's earnings history
.

What price target have analysts set for MICT?

1 Wall Street analysts have issued twelve-month target prices for MICT's stock. Their forecasts range from $4.25 to $4.25. On average, they anticipate MICT's stock price to reach $4.25 in the next year. This suggests a possible upside of 481.3% from the stock's current price.
View analysts' price targets for MICT
or view top-rated stocks among Wall Street analysts.

Who are MICT's key executives?
MICT's management team includes the following people:
  • Mr. Darren Mercer, CEO, Pres & Director (Age 58, Pay $1.34M) (LinkedIn Profile)
  • Ms. Shamian Moran-Rachel Amran, Controller (Age 42, Pay $201.77k)
  • Mr. Hao Chen, Chief Financial Officer (Age 40)
  • Mr. Richard Abrahams, MD & Global Head of Brokerage and CEO of Stock Trading & Wealth Management Bus.
What other stocks do shareholders of MICT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MICT investors own include CEL-SCI (CVM), Pfizer (PFE), Actinium Pharmaceuticals (ATNM), Nokia Oyj (NOK), Onconova Therapeutics (ONTX), Ampio Pharmaceuticals (AMPE), (APHA), Big 5 Sporting Goods (BGFV), Conformis (CFMS) and Matinas BioPharma (MTNB).

What is MICT's stock symbol?

MICT trades on the NASDAQ under the ticker symbol "MICT."

Who are MICT's major shareholders?

MICT's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (3.82%), State Street Corp (0.29%) and Bison Wealth LLC (0.15%). Company insiders that own MICT stock include Darren Mercer, Jeffrey P Bialos and Shamian Moran Rachel Amran.
View institutional ownership trends for MICT
.

Which major investors are selling MICT stock?

MICT stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc..
View insider buying and selling activity for MICT
or view top insider-selling stocks.

Which major investors are buying MICT stock?

MICT stock was acquired by a variety of institutional investors in the last quarter, including State Street Corp, and Bison Wealth LLC.
View insider buying and selling activity for MICT
or or view top insider-buying stocks.

How do I buy shares of MICT?

Shares of MICT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MICT's stock price today?

One share of MICT stock can currently be purchased for approximately $0.73.

How much money does MICT make?

MICT has a market capitalization of $89.51 million and generates $1.17 million in revenue each year.

How many employees does MICT have?

MICT employs 5 workers across the globe.

What is MICT's official website?

The official website for MICT is www.mict-inc.com.

How can I contact MICT?

MICT's mailing address is 28 West Grand Avenue Suite 3, Montvale NJ, 07645. The company can be reached via phone at (201) 225-0190 or via email at [email protected].

This page was last updated on 5/20/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.